Digital Health Intervention to Reduce Malnutrition Among Individuals With Gastrointestinal Cancer Receiving Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy: Feasibility, Acceptability, and Usability Trial
The STRONG intervention demonstrated to be feasible, acceptable, and usable among individuals with GI cancer and PD receiving CRS-HIPEC. A fully powered randomized controlled trial is needed to test the effectiveness of STRONG for reducing malnutrition and improving patient outcomes.
Authors
- Kea L. Turner (ORCID: https://orcid.org/0000-0002-7885-0879)
- Jennifer B. Permuth (ORCID: https://orcid.org/0000-0002-4726-9264)
- Jeremiah L. Deneve (ORCID: https://orcid.org/0000-0001-7664-7386)
- Seán Dineen (ORCID: https://orcid.org/0000-0002-2012-2238)
- Amir Alishahi Tabriz (ORCID: https://orcid.org/0000-0002-6273-9105)
- Olivia Sprow
- Emma Hume (ORCID: https://orcid.org/0000-0002-9344-8490)
- Benjamin Daniel Powers (ORCID: https://orcid.org/0000-0003-2679-6302)
- Yu Chen Lin (ORCID: https://orcid.org/0009-0006-6808-6615)
- R Hagen
- Jeanine Milano
- Sophia Diaz-Carraway
Institutions
- University of North Carolina at Chapel Hill (US)
- University of Maryland, Baltimore (US)
- University of North Carolina Health Care (US)
- Moffitt Cancer Center (US)
- UNC Lineberger Comprehensive Cancer Center
Publication Details
- Journal
- JMIR Cancer
- Published
- 2025-02-20
- DOI
- https://doi.org/10.2196/67108
- Citations
- 4
- Primary Topic
- Intraperitoneal and Appendiceal Malignancies
- Type
- article
- Field-Weighted Citation Impact
- 8.03